RayzeBio, Inc. financial data

Industry
Pharmaceutical Preparations
Location
5505 Morehouse Drive, Suite 300, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2023 - Nov 13, 2023

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.9M shares
Common Stock, Shares, Outstanding 59.8M shares
Common Stock, Value, Issued 6K USD
Weighted Average Number of Shares Outstanding, Basic 15.4M shares +303%
Weighted Average Number of Shares Outstanding, Diluted 15.4M shares +303%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 18.2M USD -3.5%
General and Administrative Expense 3.48M USD +64%
Operating Income (Loss) -21.7M USD -3.35%
Net Income (Loss) Attributable to Parent -18.2M USD +11%
Earnings Per Share, Basic -1.26 USD/shares +80.8%
Earnings Per Share, Diluted -1.26 USD/shares +80.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 252M USD +16.9%
Cash, Cash Equivalents, and Short-term Investments 540M USD
Assets, Current 545M USD
Property, Plant and Equipment, Net 49.7M USD
Operating Lease, Right-of-Use Asset 8.48M USD
Other Assets, Noncurrent 8K USD
Assets 604M USD
Accounts Payable, Current 2.24M USD
Employee-related Liabilities, Current 3.08M USD
Accrued Liabilities, Current 13.6M USD
Liabilities, Current 17.1M USD
Operating Lease, Liability, Noncurrent 8.46M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -386K USD
Retained Earnings (Accumulated Deficit) -180M USD
Stockholders' Equity Attributable to Parent 575M USD
Liabilities and Equity 604M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 700M shares
Common Stock, Shares, Issued 61M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 252M USD +16.8%
Operating Lease, Liability 9.72M USD
Depreciation 500K USD +25%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.2M USD +22.8%
Lessee, Operating Lease, Liability, to be Paid 12.6M USD
Property, Plant and Equipment, Gross 53M USD
Operating Lease, Liability, Current 1.27M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.13M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 2.07M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.86M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.2M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.26M USD
Operating Lease, Payments 501K USD +2.88%
Additional Paid in Capital 756M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.56M USD +77.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares